Dr.Hend El Sherbini

Dr.Hend El Sherbini has been Integrated Diagnostics Holdings (IDH) Group’s CEO since 2012, when the company was formed following the merger of Al Mokhtabar and Al Borg Laboratories.

Today, IDH is a leading consumer healthcare company in Africa and the industry leader in Egypt.

El Sherbini, who had led Al Mokhtabar since 2004, took the company public on the London Stock Exchange in 2015 and now runs a group that spans from Egypt to Sudan, Jordan and Nigeria.

This has not gone unnoticed by the global press, where she makes the rounds as one of the most powerful Egyptian and Arab women and  in business.

IDH had a network of 546 branch labs as of September 2022. The group recorded revenues of $281 million in 2021 and $143 million in the first nine months of 2022.

In August 2022, El Sherbini increased her holdings in the group with 7.3 million additional shares through Hena Holdings to reach 26.71%. In October 2022, IDH and its subsidiary Biolab announced the signing of a joint venture agreement with Fawaz Alhokair’s Izhoor Holding Medical Company to launch Greenfield Diagnostic Venture in Saudi Arabia with investments totaling $19.7 million.

Congratulations!!

Please note:

Share this report to: